These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11705287)

  • 1. Renin-angiotensin system in chronic renal allograft dysfunction.
    Shihab FS
    Contrib Nephrol; 2001; (135):222-34. PubMed ID: 11705287
    [No Abstract]   [Full Text] [Related]  

  • 2. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of angiotensin-converting-enzyme inhibitor therapy on the regulation of the plasma and cardiac tissue renin-angiotensin system in heart transplant patients.
    Kovarik JJ; Kopecky C; Antlanger M; Domenig O; Kaltenecker CC; Werzowa J; Hecking M; Mahr S; Grömmer M; Wallner C; Aumayr K; Kain R; Zuckermann A; Poglitsch M; Säemann MD
    J Heart Lung Transplant; 2017 Mar; 36(3):355-365. PubMed ID: 27773450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic allograft nephropathy. A multiple approach to target nonimmunological factors.
    Ruggenenti P
    Contrib Nephrol; 2005; 146():87-94. PubMed ID: 15567923
    [No Abstract]   [Full Text] [Related]  

  • 5. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system.
    Yamada K; Hatakeyama E; Arita S; Sakamoto K; Kashiwabara H; Hamaguchi K
    Clin Exp Nephrol; 2003 Sep; 7(3):238-42. PubMed ID: 14586721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of kidney transplants with chronic rejection using angiotensin-converting enzyme inhibitors.
    Paredes D; Sola R; Guirado L; Ibeas J; Agraz I; Vizcarra D; Algaba F
    Transplant Proc; 1997 Sep; 29(6):2587-8. PubMed ID: 9290753
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin converting enzyme inhibitor use soon after renal transplantation: a randomized, double-blinded placebo-controlled safety study.
    Glicklich D; Gordillo R; Supe K; Tapia R; Woroniecki R; Solorzano C; Coco M
    Clin Transplant; 2011; 25(6):843-8. PubMed ID: 21158922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of renin-angiotensin system in the chronic allograft nephropathy: an immunohistochemical study.
    Viero RM; da Silva MG; dos Santos DC; de Carvalho MF; de Andrade LG
    Ren Fail; 2015 Jun; 37(5):827-34. PubMed ID: 25782922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin blockade is associated with early graft dysfunction after live donor renal transplantation.
    Stevens KK; Patel RK; Clancy M; Jardine AG
    Transplantation; 2010 Mar; 89(6):707-9. PubMed ID: 20010330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The renin-angiotensin system in diabetic nephropathy.
    Chen S; Wolf G; Ziyadeh FN
    Contrib Nephrol; 2001; (135):212-21. PubMed ID: 11705286
    [No Abstract]   [Full Text] [Related]  

  • 11. Synergistic effect of mycophenolate mofetil and angiotensin-converting enzyme inhibitor in patients with chronic allograft nephropathy.
    Moscoso-Solorzano GT; Mastroianni-Kirsztajn G; Ozaki KS; Franco MF; Pacheco-Silva A; Câmara NO
    Braz J Med Biol Res; 2009 May; 42(5):445-52. PubMed ID: 19377794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin-angiotensin system blockade in biopsy-proven allograft nephropathy.
    Zaltzman JS; Nash M; Chiu R; Prasad GV
    Transplant Proc; 2003 Nov; 35(7):2415-7. PubMed ID: 14611974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Calcineurin inhibitor nephrotoxicity in renal allografts].
    Takeda A; Morozumi K
    Nihon Jinzo Gakkai Shi; 2011; 53(4):610-4. PubMed ID: 21688481
    [No Abstract]   [Full Text] [Related]  

  • 14. Blockade of the renin-angiotensin system increases graft survival in patients with chronic allograft nephropathy.
    Artz MA; Hilbrands LB; Borm G; Assmann KJ; Wetzels JF
    Nephrol Dial Transplant; 2004 Nov; 19(11):2852-7. PubMed ID: 15466882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transplant capillaropathy and transplant glomerulopathy: ultrastructural markers of chronic renal allograft rejection.
    Ivanyi B
    Nephrol Dial Transplant; 2003 Apr; 18(4):655-60. PubMed ID: 12637631
    [No Abstract]   [Full Text] [Related]  

  • 16. Renin-angiotensin system blockade and kidney transplantation: a longitudinal cohort study.
    Hernández D; Muriel A; Abraira V; Pérez G; Porrini E; Marrero D; Zamora J; González-Posada JM; Delgado P; Rufino M; Torres A
    Nephrol Dial Transplant; 2012 Jan; 27(1):417-22. PubMed ID: 21622985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct renin inhibition in a rat model of chronic allograft injury.
    Rusai K; Schmaderer C; Hermans JJ; Lutz J; Heemann U; Baumann M
    Transplantation; 2011 Nov; 92(9):999-1004. PubMed ID: 21956196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renin-angiotensin system inhibitors in kidney transplantation: a benefit-risk assessment.
    Ponticelli C; Cucchiari D
    J Nephrol; 2017 Apr; 30(2):155-157. PubMed ID: 28211033
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of single or dual blockade of renin-angiotensin system in acute myocardial infarction patients according to renal function.
    Jeong HC; Jeong JM; Jeong MH; Ahn Y; Chae SC; Hur SH; Hong TJ; Kim YJ; Seong IW; Chae JK; Rhew JY; Chae IH; Cho MC; Bae JH; Rha SW; Kim CJ; Choi D; Jang YS; Yoon J; Chung WS; Cho JG; Seung KB; Park SJ;
    Int J Cardiol; 2012 Jun; 157(3):408-11. PubMed ID: 22513185
    [No Abstract]   [Full Text] [Related]  

  • 20. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.